Target Price | $305.49 |
Price | $235.02 |
Potential | 29.98% |
Number of Estimates | 34 |
34 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $305.49. This is 29.98% higher than the current stock price. The highest price target is $525.00 123.39% , the lowest is $195.94 16.63% . | |
A rating was issued by 41 analysts: 24 Analysts recommend Lululemon Athletica to buy, 14 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 29.98% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
37 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.5b . This is 6.60% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $12.0b 11.22% , the lowest is $10.4b 2.84% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.5b | 8.22% |
2027 | $12.3b | 7.16% |
2028 | $12.8b | 4.52% |
2029 | $13.2b | 2.52% |
2030 | $14.3b | 8.70% |
2031 | $17.3b | 20.71% |
2032 | $18.7b | 8.31% |
2033 | $20.2b | 7.96% |
32 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.1b . This is 21.66% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.3b 31.75% , the lowest is $2.4b 2.78% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.5b | 13.55% |
---|---|---|
2026 | $3.1b | 21.86% |
2027 | $3.3b | 7.64% |
2028 | $3.4b | 4.23% |
2029 | $3.5b | 1.03% |
2030 | $3.8b | 8.45% |
2031 | $4.6b | 22.80% |
2032 | $5.0b | 7.94% |
2033 | $5.4b | 7.70% |
2025 | 23.72% | 3.16% |
---|---|---|
2026 | 26.71% | 12.59% |
2027 | 26.83% | 0.45% |
2028 | 26.76% | 0.26% |
2029 | 26.37% | 1.46% |
2030 | 26.31% | 0.23% |
2031 | 26.76% | 1.71% |
2032 | 26.67% | 0.34% |
2033 | 26.61% | 0.22% |
38 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.9b . This is 3.51% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.0b 9.03% , the lowest is $1.4b 21.99% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 17.06% |
---|---|---|
2026 | $1.9b | 3.12% |
2027 | $2.0b | 8.01% |
2028 | $2.1b | 4.11% |
2029 | $2.4b | 14.96% |
2030 | $2.7b | 9.98% |
2031 | $3.7b | 38.99% |
2032 | $4.2b | 13.60% |
2033 | $4.8b | 13.31% |
2025 | 17.14% | 6.35% |
---|---|---|
2026 | 16.33% | 4.72% |
2027 | 16.46% | 0.80% |
2028 | 16.39% | 0.43% |
2029 | 18.38% | 12.14% |
2030 | 18.60% | 1.20% |
2031 | 21.42% | 15.16% |
2032 | 22.46% | 4.86% |
2033 | 23.57% | 4.94% |
38 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $14.95 . This is 0.00% lower than earnings per share in the financial year 2025. The highest EPS forecast is $15.75 5.35% , the lowest is $11.27 24.62% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $14.95 | 2.12% |
2027 | $16.15 | 8.03% |
2028 | $16.81 | 4.09% |
2029 | $19.33 | 14.99% |
2030 | $21.26 | 9.98% |
2031 | $29.55 | 38.99% |
2032 | $33.57 | 13.60% |
2033 | $38.04 | 13.32% |
Current | 15.72 | 36.93% |
---|---|---|
2026 | 15.72 | 0.00% |
2027 | 14.55 | 7.44% |
2028 | 13.77 | 5.36% |
2029 | 11.98 | 13.00% |
2030 | 10.89 | 9.10% |
2031 | 7.95 | 27.00% |
2032 | 7.00 | 11.95% |
2033 | 6.18 | 11.71% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 2.45 and an P/S ratio of 2.56 .
This results in the following potential growth metrics and future valuations:
Current | 2.61 | 27.70% |
---|---|---|
2026 | 2.45 | 6.23% |
2027 | 2.28 | 6.69% |
2028 | 2.15 | 5.81% |
2029 | 2.10 | 2.46% |
2030 | 1.93 | 8.01% |
2031 | 1.62 | 15.85% |
2032 | 1.50 | 7.67% |
2033 | 1.39 | 7.38% |
Current | 2.73 | 28.18% |
---|---|---|
2026 | 2.56 | 6.19% |
2027 | 2.39 | 6.68% |
2028 | 2.25 | 5.75% |
2029 | 2.20 | 2.46% |
2030 | 2.02 | 8.01% |
2031 | 1.70 | 15.91% |
2032 | 1.57 | 7.67% |
2033 | 1.45 | 7.37% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
CICC |
Outperform
➜
Market Perform
|
Downgrade | Jun 09 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jun 09 2025 |
Morgan Stanley |
Overweight
➜
Equal-Weight
|
Downgrade | Jun 09 2025 |
BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Jun 06 2025 |
BTIG |
Buy
➜
Buy
|
Unchanged | Jun 06 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 06 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Jun 06 2025 |
Analyst Rating | Date |
---|---|
Downgrade
CICC:
Outperform
➜
Market Perform
|
Jun 09 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jun 09 2025 |
Downgrade
Morgan Stanley:
Overweight
➜
Equal-Weight
|
Jun 09 2025 |
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Jun 06 2025 |
Unchanged
BTIG:
Buy
➜
Buy
|
Jun 06 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 06 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Jun 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.